Research Appraisalother

Laser-Engineered MXene Heterostructure for Wearable Ammonia Sensors

ACS sensorsLi, Donghang, Wang, Yida, Wang, Haomin et al.24 Apr 2026DOI

Clinical Snapshot

75CEBM
Evidence: Moderateother

PICO Framework

P — PopulationNot applicable - materials science/engineering study with potential clinical applications for patients requiring breath ammonia monitoring
I — InterventionLaser-engineered MXene (LEM) sensor technology using Ti3C2Tx MXene/polyacrylonitrile nanofiber membranes
C — ComparatorConventional MXene-based sensors and traditional ammonia detection methods
O — OutcomesSensor sensitivity (2.5% ppm-1), detection limit (0.2 ppm), humidity stability, and room temperature operation

Bottom Line

This materials science study presents a promising laser-engineered sensor technology for detecting ammonia in exhaled breath, potentially enabling non-invasive monitoring of liver and kidney function. The sensor demonstrates superior sensitivity (2.5% ppm-1) and maintains performance in high humidity conditions - addressing key limitations of existing technologies. However, this remains early-stage technology development without clinical validation. While the technical advances are significant, clinicians should await human studies demonstrating correlation between breath ammonia levels and clinical outcomes before considering clinical applications. The room-temperature operation and humidity resistance suggest potential for practical wearable devices, but regulatory approval and cost-effectiveness studies will be essential for clinical adoption.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: Five-fold improvement over conventional MXene-based sensors

  • Primary Outcome: Sensor sensitivity of 2.5% ppm-1 for ammonia detection

  • Nnt Or Sensitivity: Detection limit: 0.2 ppm ammonia with >10% response maintained at 90% relative humidity

  • Confidence Interval: Not reported

Clinical Application

High technical feasibility for wearable integration, but requires clinical validation and regulatory approval Potential TGA medical device pathway required; could complement existing liver function monitoring under Medicare if clinically validated Patients requiring non-invasive monitoring of hepatorenal function and metabolic disorders through breath ammonia analysis

Abstract

Exhaled ammonia is a vital biomarker for clinical diagnosis of hepatorenal dysfunction and metabolic disorders. However, conventional sensors are often limited by complex fabrication processes, high operating temperatures, and particularly, compromised selectivity under high-humidity conditions. To overcome these challenges, we developed a laser-assisted heterostructure engineering strategy that enables in situ construction of Schottky barrier in MXene/polyacrylonitrile (PANF) nanofiber membranes, termed as a laser-engineered MXene (LEM) sensor. The laser micropatterning technique provides three key innovations: (1) kinetically controlled deposition of MXene (Ti3C2Tx) with minimal oxidation, (2) self-aligned formation of Schottky barriers through interfacial TiO2/MXene heterojunctions, and (3) creation of hierarchical gas transport channels within the 3D nanofibrous matrix. The optimized LEM sensor exhibits outstanding sensitivity (2.5% ppm-1), a low detection limit (0.2 ppm) at room temperature (25 °C), and humidity operation stability (> 10% response at 90% relative humidity). This performance surpasses that of conventional MXene-based sensors by fivefold in sensitivity without the need for thermal activation. Mechanism studies reveal that the laser-induced heterointerface facilitates charge transfer-dominated ammonia adsorption and desorption kinetics, while the nanofibrous architecture ensures molecular accessibility to active sites. This ambient-processable and scalable fabrication method paves the way for advanced wearable breath analyzers by combining manufacturing versatility, humidity-resistant excellent selectivity, and energy-efficient operation.

Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service